{
  "id": 19398462,
  "title": "Cigna at 2026 UBS Global Healthcare Conference: growth plan in focus",
  "url": "https://urgent.news/2026/11/10/cigna-at-2026-ubs-global-healthcare-conference-growth-plan-in-focus",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T21:24:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/cigna-at-2026-ubs-global-healthcare-conference-growth-plan-in-focus-93CH-5016895"
  },
  "original_language": "en",
  "account": "On November 10, 2026, Cigna Group announced its long-term growth plan during the 2026 UBS Global Healthcare Conference. Management outlined a strategy focusing on steady growth and addressing near-term challenges in pharmacy benefit services (PBS). The company aimed to reach its 2030 earnings goals through expansion in specialty care, effective healthcare operations, and productivity savings, despite a projected trough year in PBS for 2027.\n\nCigna affirmed its target of $45 in earnings per share by 2030, anticipating a 10% to 14% annual growth rate. No single business was expected to carry this target, providing a form of downside protection. PBS was forecast to face headwinds in 2027, followed by recovery from 2028 onward with the launch of the Signature transparent PBM model on January 1, 2028. Ann Dennison, Cigna's CFO, explained that the $45 earnings goal assumed no growth in PBS over the period, serving as the minimum threshold.\n\nSpecialty care was identified as the main growth engine, accounting for 37% of earnings today and expected to reach around 40% by 2030. This segment had a 13% compound annual growth rate from 2023 to 2026, outpacing the company's long-term target of 8% to 12%. GLP-1 coverage in the corporate market was predicted to moderate, with a shrinking rebate pool due to price reductions from the Inflation Reduction Act. Despite this, Cigna remained optimistic about earning money from GLP-1 coverage, albeit with less favorable economics compared to previous periods.\n\nIn a bid to address employer concerns, Cigna introduced the Signature transparent PBM model. The model is designed to provide transparent pricing, ensure price assurance, and offer fee-based and predictable per-member-per-month costs. The model began rolling out for external clients on January 1, 2028, with the goal of delivering the lowest price at the point of sale. Dennison highlighted Signature as a key differentiator for Cigna, aiming for a 4% margin on non-mega clients and positioning the company for growth post-2027.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}